Please login or register first to view this content.
Topics
Model Shows Combined Efforts May Cut SARS-CoV-2 Infections
Long-Acting Cabotegravir + Rilpivirine Noninferior to Standard Treatment for HIV
Interim AHA Guidelines for Reducing COVID-19 Transmission During Resuscitation
PPE Negative for SARS-CoV-2 After Patient Contact
Rotavirus Vaccination Reduces Children Hospitalizations and Deaths
Workers at Risk for COVID-19 Exposure Can Access Online Training
FDA to Review Baloxavir for Pediatric Use, Postexposure Prophylaxis of Influenza
FDA Allows Use of COVID-19 Convalescent Plasma for Severely Ill Patients Under Emergency IND
Fostemsavir Active in Multidrug-Resistant HIV-1 Infection
Current Figures May Underestimate COVID-19 Mortality in Symptomatic Patients
Multiple-Dose Fosfomycin for Complicated UTIs
HPV Biomarkers, Survival Linked to High-Grade Esophageal Dysplasia, Adenocarcinoma
Managing HBV Infection During Pregnancy
Subclinical PFT Abnormalities Often Found in Pediatric Chronic Hepatitis B
Concurrent HCV Treatment, Opioid Agonist Therapy Results in High Cure Rates, Reduced Drug Use Risk
Serum HBsAg: A Biomarker for HBV-specific T- and B-Cell Responses
Risk Model for Hepatocellular Carcinoma Among Chronic HCV Patients
Dried Blood Spot Viral Load More Accurate Than Plasma Viral Load in HIV?
Buprenorphine Treatment Linked to Decreased HIV RNA Viral Loads
Cardiac Events Significantly Higher With TAF vs TDF Treatment for HIV
Pulmonary Tuberculosis Enhances HIV-1 Antibody Responses
Sofosbuvir/Velpatasvir Combination Therapy Efficacious in HCV/HIV Coinfection
Increased Cardiovascular Disease Risk Among Youth Living With HIV
Point-of-Care Test Shows Early Promise for Diagnosing Neurosyphilis
Hepatic Steatosis in People With HIV, People who Use Intravenous Drugs
Study Findings Suggestive of Second HIV Cure Case: The London Patient
Transmission of DAA Resistance Inhibits Cure Rates Among HIV/HCV Coinfected MSM
Telmisartan Adjunct Treatment May Reduce CNS Inflammation During Acute HIV
Two-Drug Antiretroviral Therapy May Decrease Resistance, Toxicity in PLWHIV
DUALIS Results Show Switch to 2-Drug Regimen Is Effective in Patients With HIV
Women Less Likely to Receive Screening or Counseling For HIV at STI Diagnosis
Dolutegravir Improves Lipids Blood Concentration, But Increases Trunk Fat in Youths With HIV
Countries’ Mitigation Measures Crucial for Containing Spread of COVID-19
Hepatitis B Exposure Risk, Prevalence in the US Adult Homeless Population
New Long-Acting Two-Drug Injectable Regimen for Maintaining HIV Suppression
20-Valent Pneumococcal Conjugate Vaccine Safe, Immunogenic in Phase 3 Trial
FDA Issues Statement Regarding NSAID Use and COVID-19
Phase 1 Study of Investigational mRNA Vaccine for COVID-19 Underway
FDA: Thermo Fisher COVID-19 Test Gets Emergency Use Authorization
Hepatocellular Carcinoma Prediction Beyond Year 5 of Therapy in Chronic Hepatitis B
Health Professionals Call for Revisions to US Restrictions on Physicians’ Scope of Practice
HCV Cure Shows No Effect on Markers of Preclinical Atherosclerosis in HIV/HCV Coinfection
Updated Guidelines for Latent TB Infection Treatment Released by CDC and NTCA
Decreased Antibiotic Susceptibility of S pneumoniae Strains
Possible Case of Locally Acquired Chagas Disease in Missouri
Mental Health Concerns Arise Amid COVID-19 Epidemic
Older Women With HIV Have Worse Physical Function, Quality of Life
C difficile Risk and Antibiotic Prescription Choices
Millions of Coronavirus Test Kits Available Soon, Vice President Says
Want to read more?
Next post in HIV/AIDS
